Thursday - May 22, 2025
Arbor Biotechnologies to Present Foundational Data for PH1 and CNS Programs at the American Society of Gene and Cell Therapy 28th Annual Meeting
April 29, 2025
CAMBRIDGE, Massachusetts, April 29 -- Arbor Biotechnologies, a biotechnology company that says it discovers and develops genetic medicines, issued the following news release:

* * *

Arbor Biotechnologies to Present Foundational Data for PH1 and CNS Programs at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting

* Oral presentation to include preclinical data supporting the clinical advancement of ABO-101 for the treatment of primary hyp . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products